Ypsomed Holding AG header image

Ypsomed Holding AG

YPSN

Equity

ISIN CH0019396990 / Valor 1939699

SIX Swiss Exchange (2026-09-23)
CHF 358.20+0.06%

Ypsomed Holding AG
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Ypsomed Holding AG is a Swiss company specializing in the development and production of injection and infusion systems for self-medication, primarily serving the pharmaceutical and biotechnology sectors. The company operates through two main divisions: Ypsomed Delivery Systems (YDS) and mylife Diabetescare. YDS provides a wide array of technologies and services designed to ensure reliable and user-friendly injection systems, catering to companies that develop and market injectable therapies. Meanwhile, the mylife Diabetescare brand offers a comprehensive range of products and services aimed at simplifying self-treatment for individuals with diabetes, enhancing their ability to manage their condition discreetly and effectively. Ypsomed's focus on innovation and user-centric design positions it as a key player in the medical technology industry, particularly in the field of self-administered drug delivery solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

2.34%1Y
34.9%3Y
141%5Y

Performance

33.0%1Y
32.1%3Y
31.7%5Y

Volatility

Market cap

5710 M

Market cap (USD)

Daily traded volume (Shares)

15,015

Daily traded volume (Shares)

1 day high/low

340 / 328

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.50
Khiem Tran
Switzerland, 02 Nov 2025
star star star star star
There is potential but it’s right now lagging.
Khiem Tran
Switzerland, 31 Oct 2025
star star star star star
Ypsomed is under Track because of the high potential innovation and R&D.

EQUITIES OF THE SAME SECTOR

AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.05%USD 265.08
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.90%USD 28.18
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.77%USD 61.15
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%USD 298.41
Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.57%USD 106.82
Elevance Health Inc
Elevance Health Inc Elevance Health Inc Valor: 26124340
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%USD 398.56
Zoetis Inc
Zoetis Inc Zoetis Inc Valor: 19276994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.72%USD 71.61
Becton Dickinson & Co.
Becton Dickinson & Co. Becton Dickinson & Co. Valor: 912061
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 182.52
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%USD 44.62
Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.96%USD 227.53